Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Krach, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krach, L. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pharmacotherapy of Spasticity: Oral Medications and Intrathecal Baclofen

Linda E. Krach

Gillette Children's Specialty Healthcare, 200 E. University Ave., St. Paul, MN 55101

Spasticity is a common problem in children with neurologic impairment, particularly in those with cerebral palsy. Clinicians commonly make use of oral medications to attempt to reduce spasticity and increase function. Little has been published in the literature concerning the use of these medications in children and their effects on both muscle tone and function. This article is a review of the sites of action, side effects, and efficacy of benzodiazepines, baclofen, dantrolene sodium, alpha2-adrenergic agonists, and gabapentin. A brief review of intrathecal baclofen is included as well. (J Child Neurol 2001;16:31-36).

Journal of Child Neurology, Vol. 16, No. 1, 31-36 (2001)
DOI: 10.1177/088307380101600106
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
L.M. Nagae, A.H. Hoon Jr., E. Stashinko, D. Lin, W. Zhang, E. Levey, S. Wakana, H. Jiang, C.C. Leite, L.T. Lucato, et al.
Diffusion Tensor Imaging in Children with Periventricular Leukomalacia: Variability of Injuries to White Matter Tracts
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1213 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Pohl, E. Waubant, B. Banwell, D. Chabas, T. Chitnis, B. Weinstock-Guttman, S. Tenembaum, and for the International Pediatric MS Study Group
Treatment of pediatric multiple sclerosis and variants
Neurology, April 17, 2007; 68(16_suppl_2): S54 - S65.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
G. de Lissovoy, L. S. Matza, H. Green, M. Werner, and T. Edgar
Cost-effectiveness of Intrathecal Baclofen Therapy for the Treatment of Severe Spasticity Associated With Cerebral Palsy
J Child Neurol, January 1, 2007; 22(1): 49 - 59.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
L. Lubsch, R. Habersang, M. Haase, and S. Luedtke
Oral Baclofen and Clonidine for Treatment of Spasticity in Children
J Child Neurol, December 1, 2006; 21(12): 1090 - 1092.
[Abstract] [PDF]

Home page
 Pharmacol. Rev.Home page
N. G. Bowery, B. Bettler, W. Froestl, J. P. Gallagher, F. Marshall, M. Raiteri, T. I. Bonner, and S. J. Enna
International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function
Pharmacol. Rev., June 1, 2002; 54(2): 247 - 264.
[Abstract] [Full Text] [PDF]